View live charts, options flow & technicals for Henry Schein, Inc. →
Open Dashboard
Henry Schein, Inc. (HSIC) is a healthcare company in the medical distribution industry with $13.60B in trailing revenue trading at a 25.2× trailing P/E — analyst consensus: buy.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Key Statistics
Market Cap
$9.63B
Revenue (TTM)
$13.60B
EPS (TTM)
$3.43
EPS (Fwd est.)
$5.99
Employees
25,000
Trailing P/E
25.18
Forward P/E
14.42
PEG Ratio
1.71
Price / Sales
0.71
Price / Book
3.06
EV / EBITDA
13.75
Beta (5Y)
0.81
Analyst Consensus
Consensus
Buy
Analyst Price Target
+12.6% upside
Target: $97.27
Annual Revenue & Net Income
RevenueNet Income
'22
$12.65B
$540.00M
'23
$12.34B
$420.00M
'24
$12.67B
$390.00M
'25
$13.18B
$400.00M
Earnings History
Quarter
Actual EPS
Estimate
Result
Aug 2026
$1.27
$1.24
Beat (+2.5%)
May 2026
$1.32
$1.22
Beat (+8.4%)
Feb 2026
$1.34
$1.29
Beat (+3.5%)
Nov 2025
$1.38
$1.28
Beat (+7.9%)
Next Earnings Report
Henry Schein, Inc. is next expected to report earnings on 03 Nov 2026.
Profitability
31.3%
5.8%
3.0%
Gross MarginOperating MarginNet Margin
Revenue Growth (YoY)
6.7%
Return on Equity
8.9%
Return on Assets
4.4%
Balance Sheet
Cash & Equivalents
$160.00M
Total Debt
$3.81B
Net Position
$3.66B (net debt)
Free Cash Flow (TTM)
$450.00M
Debt / Equity
80.73
Share Ownership
Institutions 112.3%
Insiders 0.8%
Institutional figure exceeds 100% due to short selling
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composi…
What is HSIC's market cap?
Henry Schein, Inc. has a market capitalization of approximately $9.63B.
What is HSIC's P/E ratio?
Henry Schein, Inc. trades at a trailing P/E ratio of 25.2x and a forward P/E of 14.4x, which is above the broad market average of ~25x.
How much revenue does HSIC generate?
Henry Schein, Inc. generated $13.60B in trailing 12-month revenue.
What do analysts say about HSIC?
The analyst consensus rating for Henry Schein, Inc. is buy, with a mean price target of $97.27. That implies +12.6% upside from the current price.
When does HSIC report earnings?
Henry Schein, Inc. is next scheduled to report earnings on 03 Nov 2026.
Does HSIC pay a dividend?
Henry Schein, Inc. does not currently pay a regular dividend.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Henry Schein, Inc. on Apsis Markets.